ArticleTherapeutic advances in infectious disease

Patient-reported outcomes among people living with HIV switching to dual therapy with dolutegravir/lamivudine: results from the PROBI study.

Martin Duracinsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.